|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.06 CNY | -3.01% |
|
+1.29% | -7.53% |
| 06-09 | China Approves Aodong Subsidiary's Levocarnitine Injection | MT |
| 05-21 | Jilin Aodong Pharmaceutical Gets China Approval for Supplemental Registration of Heart Drug | MT |
| Market Cap | 21.17B 3.12B 2.73B 2.52B 2.32B 4.38B 301B 4.47B 30.11B 11.84B 147B 11.73B 11.47B 507B | P/E 2024 |
13.1x | P/E 2025 | 9.57x |
|---|---|---|---|---|---|
| Enterprise Value | 20.45B 3.02B 2.64B 2.43B 2.24B 4.23B 291B 4.32B 29.08B 11.44B 142B 11.33B 11.08B 490B | EV / Sales 2024 |
7.76x | EV / Sales 2025 | 9.49x |
| Free-Float |
67.59% | Yield 2024 |
2.9% | Yield 2025 | 2.56% |
| 1 day | -3.01% | ||
| 1 week | +1.29% | ||
| Current month | +1.86% | ||
| 1 month | +1.01% | ||
| 3 months | -1.79% | ||
| 6 months | -10.10% | ||
| Current year | -7.53% |
| 1 week | 17.27 |  | 18.79 |
| 1 month | 17.08 | | 18.88 |
| Current year | 16.36 | | 20.93 |
| 1 year | 16.36 | | 22.08 |
| 3 years | 12.49 | | 22.08 |
| 5 years | 12.49 | | 22.08 |
| 10 years | 12.49 | | 29.43 |
| Manager | Title | Age | Since |
|---|---|---|---|
Shu Qin Guo
CEO | Chief Executive Officer | 63 | 2017-07-16 |
Kai Yang
DFI | Director of Finance/CFO | 49 | 2004-04-30 |
Shu Yuan Zhang
DFI | Director of Finance/CFO | 54 | 2007-06-17 |
| Director | Title | Age | Since |
|---|---|---|---|
Xiu Lin Li
CHM | Chairman | 73 | 2005-05-17 |
Shu Qin Guo
BRD | Director/Board Member | 63 | 2000-01-31 |
Yong Feng Chen
CHM | Chairman | 59 | 2017-07-16 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 11/25/25 | Buy | 100 | 0.0000% | |||
| 7/29/24 | Buy | Chief Executive Officer | 320,000 | 0.0276% | ||
| 7/29/24 | Buy | Chairman | 350,000 | 0.0302% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.01% | +1.29% | -0.44% | +11.55% | 3.22B | |
| +0.85% | -0.80% | +54.84% | +163.70% | 1,043B | |
| +1.23% | -1.53% | +55.26% | +59.07% | 602B | |
| +0.04% | +2.58% | +32.96% | +88.75% | 449B | |
| +0.78% | -0.39% | +30.44% | +23.23% | 327B | |
| +1.41% | +0.56% | +31.41% | +47.13% | 279B | |
| -0.27% | -5.69% | +20.68% | +21.99% | 264B | |
| -1.42% | +0.80% | +22.81% | +60.77% | 201B | |
| -1.48% | +3.43% | +23.42% | +73.31% | 169B | |
| -0.36% | +3.64% | +1.91% | -30.15% | 143B | |
| Average | -0.24% | -0.30% | +27.33% | +51.94% | 348.03B | |
| Weighted average by Cap. | +0.42% | -1.81% | +39.72% | +84.18% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.61B 385M 337M 311M 286M 540M 37.09B 552M 3.71B 1.46B 18.17B 1.45B 1.41B 62.53B | 2.34B 345M 301M 278M 256M 483M 33.18B 493M 3.32B 1.31B 16.25B 1.29B 1.27B 55.94B |
| Net income | 1.55B 229M 200M 185M 170M 321M 22.04B 328M 2.21B 868M 10.8B 860M 841M 37.16B | 2.4B 353M 309M 285M 263M 495M 34.03B 506M 3.41B 1.34B 16.67B 1.33B 1.3B 57.37B |
| Net Debt | -386M -56.94M -49.76M -45.92M -42.33M -79.78M -5.48B -81.55M -549M -216M -2.69B -214M -209M -9.25B | -724M -107M -93.34M -86.14M -79.4M -150M -10.29B -153M -1.03B -405M -5.04B -401M -392M -17.34B |
Employees
5,461
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-16 | CN¥18.06 | -3.01% | 21,590,950 |
| 26-07-16 | CN¥18.62 | -0.21% | 20,506,958 |
| 26-07-15 | CN¥18.66 | +4.30% | 27,751,556 |
| 26-07-14 | CN¥17.89 | +2.23% | 15,633,702 |
| 26-07-13 | CN¥17.50 | -0.79% | 12,861,097 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 000623 Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
